Hengdli Pharmaceutical (301211.SZ): Approval of the application for listing of metoclopramide hydrochloride as a chemical raw material drug.

Zhifeng financial news app, Hengdi Pharmaceuticals (301211.SZ) announced that the company has recently received the "Notice of Approval of the Market Application for Chemical Raw Materials" regarding the hydrochloride of metoclopramide issued by the National Medical Products Administration. Metoclopramide hydrochloride is a dopamine receptor antagonist mainly used to relieve symptoms of nausea and vomiting, and can also promote gastrointestinal motility to improve problems such as indigestion and delayed gastric emptying.